- Apr 2, 2009
- 5,171
- 13,288
- 68
Today's Journal of the American Medical Association contained several articles and editorials by e-cig opponents that repeated false and misleading claims about e-cigs, and that lobbied for FDA regulations on e-cigs.
The following three articles are free to the public.
Experts call for research plus regulation of e-cigarettes
JAMA Network | JAMA | Experts Call for Research Plus Regulation of e-Cigarettes
e-Cigarettes
JAMA Network | JAMA | e-Cigarettes
JAMA The medical letter on drug and therapeutics: Electronic Cigarettes
JAMA Network | JAMA | Electronic Cigarettes
The following articles in JAMA cost money, but I'll be pleased to send a free copy to those who send an e-mail request to me at smokefree@compuserve.com
Viewpoint
Promise and Peril of e-Cigarettes: Can Disruptive Technology Make Cigarettes Obsolete?
JAMA. 2014;311(2):135-136. doi:10.1001/jama.2013.28534
David B. Abrams
JAMA Network | JAMA | Promise and Peril of e-Cigarettes: Can Disruptive Technology Make Cigarettes Obsolete?
CDC: Use of Emerging tobacco Products Increasing Among US Youths
JAMA. 2014;311(2):124. doi:10.1001/jama.2013.285837.
Mike Mitka
JAMA Network | JAMA | CDC: Use of Emerging Tobacco Products Increasing Among US Youths
tobacco Control and Progress
JAMA. 2014;311(2):133-134. doi:10.1001/jama.2013.284534.
Tom Frieden
JAMA Network | JAMA | Tobacco Control Progress and Potential
JAMA Editorial
Tobacco Control 50 years after the 1964 Surgeon Generals Report
JAMA. 2014;311(2):141-143. doi:10.1001/jama.2013.285243.
Stephen Schroeder, Howard Koh
JAMA Network | JAMA | Tobacco Control 50 Years After the 1964 Surgeon General
The war against tobacco: 50 years and counting
JAMA. 2014;311(2):131-132. doi:10.1001/jama.2013.280767.
Helene Cole, Michael Fiore
JAMA Network | JAMA | The War Against Tobacco: 50 Years and Counting
The JAMA issue also contained the following article touting a study treating smokers with varenicline (i.e. Chantix) and burproprian, whose authors issued the following press release.
Combined therapy benefits cigarette smokers trying to quit compared to monotherapy
Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers: A Randomized Trial
JAMA. 2014;311(2):155-163. doi:10.1001/jama.2013.283185
Jon O. Ebbert, Dorothy K. Hatsukami, Ivana T. Croghan, Darrell R. Schroeder, Sharon S. Allen, J. Taylor Hays, Richard D. Hurt
JAMA Network | JAMA | Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers: A Randomized Trial
The following three articles are free to the public.
Experts call for research plus regulation of e-cigarettes
JAMA Network | JAMA | Experts Call for Research Plus Regulation of e-Cigarettes
e-Cigarettes
JAMA Network | JAMA | e-Cigarettes
JAMA The medical letter on drug and therapeutics: Electronic Cigarettes
JAMA Network | JAMA | Electronic Cigarettes
The following articles in JAMA cost money, but I'll be pleased to send a free copy to those who send an e-mail request to me at smokefree@compuserve.com
Viewpoint
Promise and Peril of e-Cigarettes: Can Disruptive Technology Make Cigarettes Obsolete?
JAMA. 2014;311(2):135-136. doi:10.1001/jama.2013.28534
David B. Abrams
JAMA Network | JAMA | Promise and Peril of e-Cigarettes: Can Disruptive Technology Make Cigarettes Obsolete?
CDC: Use of Emerging tobacco Products Increasing Among US Youths
JAMA. 2014;311(2):124. doi:10.1001/jama.2013.285837.
Mike Mitka
JAMA Network | JAMA | CDC: Use of Emerging Tobacco Products Increasing Among US Youths
tobacco Control and Progress
JAMA. 2014;311(2):133-134. doi:10.1001/jama.2013.284534.
Tom Frieden
JAMA Network | JAMA | Tobacco Control Progress and Potential
JAMA Editorial
Tobacco Control 50 years after the 1964 Surgeon Generals Report
JAMA. 2014;311(2):141-143. doi:10.1001/jama.2013.285243.
Stephen Schroeder, Howard Koh
JAMA Network | JAMA | Tobacco Control 50 Years After the 1964 Surgeon General
The war against tobacco: 50 years and counting
JAMA. 2014;311(2):131-132. doi:10.1001/jama.2013.280767.
Helene Cole, Michael Fiore
JAMA Network | JAMA | The War Against Tobacco: 50 Years and Counting
The JAMA issue also contained the following article touting a study treating smokers with varenicline (i.e. Chantix) and burproprian, whose authors issued the following press release.
Combined therapy benefits cigarette smokers trying to quit compared to monotherapy
Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers: A Randomized Trial
JAMA. 2014;311(2):155-163. doi:10.1001/jama.2013.283185
Jon O. Ebbert, Dorothy K. Hatsukami, Ivana T. Croghan, Darrell R. Schroeder, Sharon S. Allen, J. Taylor Hays, Richard D. Hurt
JAMA Network | JAMA | Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers: A Randomized Trial